新天地药业股份有限公司2025年半年度报告摘要

Group 1 - The company did not distribute cash dividends, issue bonus shares, or increase capital from reserves during the reporting period [2] - There were no changes in the controlling shareholder or actual controller during the reporting period [3] - The company does not have any preferred shareholders or related holdings to report for the current period [3] Group 2 - The company does not require retrospective adjustments or restatements of previous accounting data [2] - There are no significant matters reported during the period [3] - The company has confirmed that all directors attended the board meeting to review the report [1]